BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7990324)

  • 1. [Treatment of diabetic foot gangrene].
    Lémb DU
    Khirurgiia (Mosk); 1994 Aug; (8):52-6. PubMed ID: 7990324
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience with microbiological studies of the diabetic foot].
    Kajetán M; Konkoly TM; Jermendy G
    Orv Hetil; 1995 Oct; 136(40):2161-4. PubMed ID: 7566949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections.
    Goldstein EJ; Citron DM; Warren YA; Tyrrell KL; Merriam CV; Fernandez HT
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2875-9. PubMed ID: 16870792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bacteriology of diabetic foot ulcers in Port Harcourt, Nigeria.
    Unachukwu CN; Obunge OK; Odia OJ
    Niger J Med; 2005; 14(2):173-6. PubMed ID: 16083241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Consensus document on the antimicrobial treatment of diabetic-foot infections].
    ; ; ;
    Rev Esp Quimioter; 2007 Mar; 20(1):77-92. PubMed ID: 17530039
    [No Abstract]   [Full Text] [Related]  

  • 6. Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases.
    Raja NS
    J Microbiol Immunol Infect; 2007 Feb; 40(1):39-44. PubMed ID: 17332905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of tigecycline against strains isolated from diabetic foot ulcers.
    Sotto A; Bouziges N; Jourdan N; Richard JL; Lavigne JP
    Pathol Biol (Paris); 2007 Nov; 55(8-9):398-406. PubMed ID: 17905534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bacteriological profile of diabetic foot and its impact on the choice of antibiotics].
    Zemmouri A; Tarchouli M; Benbouha A; Lamkinsi T; Bensghir M; Elouennass M; Haimeur C
    Pan Afr Med J; 2015; 20():148. PubMed ID: 27386024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue and serum levofloxacin concentrations in diabetic foot infection patients.
    Oberdorfer K; Swoboda S; Hamann A; Baertsch U; Kusterer K; Born B; Hoppe-Tichy T; Geiss HK; von Baum H
    J Antimicrob Chemother; 2004 Oct; 54(4):836-9. PubMed ID: 15375105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathogenesis and combined surgical treatment of the pyonecrotic diabetic foot].
    Svetukhin AM; Zemlianoĭ AB; Istratov VG; Korotkina RN; Terekhova RP; Puchkova LS; Makhmudova LS
    Khirurgiia (Mosk); 2003; (3):85-8. PubMed ID: 12698661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic choices in the infected diabetic foot/ulcer.
    Waspadji S
    Acta Med Indones; 2005; 37(2):94-101. PubMed ID: 15925854
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antibacterial treatment in diabetic foot syndrome].
    Svetukhin AM; Iakovlev VP; Blatun LA; Terekhova RP; Ukhin SA
    Antibiot Khimioter; 2003; 48(11):31-7. PubMed ID: 15106309
    [No Abstract]   [Full Text] [Related]  

  • 13. Update on the treatment of diabetic foot infections.
    Kosinski MA; Joseph WS
    Clin Podiatr Med Surg; 2007 Jul; 24(3):383-96, vii. PubMed ID: 17613382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clindamycin-resistant Streptococcus pyogenes: report of a case.
    Walsh SR; Ferraro MJ; Durand ML
    Diagn Microbiol Infect Dis; 2004 Jul; 49(3):223-5. PubMed ID: 15246514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of fungal and bacterial infections of the diabetic foot.
    Chincholikar DA; Pal RB
    Indian J Pathol Microbiol; 2002 Jan; 45(1):15-22. PubMed ID: 12593559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of pathogens in diabetic foot infection in South Indian type 2 diabetic patients.
    Viswanathan V; Jasmine JJ; Snehalatha C; Ramachandran A
    J Assoc Physicians India; 2002 Aug; 50():1013-6. PubMed ID: 12421021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of polymicrobial intra-abdominal, pelvic, and diabetic foot infections.
    Zervos M
    Compr Ther; 1998; 24(6-7):295-301. PubMed ID: 9669093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diabetic foot infections: the importance of bacterial resistance].
    Barberán J
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):315-6. PubMed ID: 19481840
    [No Abstract]   [Full Text] [Related]  

  • 19. Are clindamycin and ciprofloxacin appropriate for the empirical treatment of diabetic foot infections?
    de Vries MG; Ekkelenkamp MB; Peters EJ
    Eur J Clin Microbiol Infect Dis; 2014 Mar; 33(3):453-6. PubMed ID: 24220766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of bacteria from a non-healing diabetic foot wound by 16 S rDNA sequencing.
    Redkar R; Kalns J; Butler W; Krock L; McCleskey F; Salmen A; Piepmeier E; DelVecchio V
    Mol Cell Probes; 2000 Jun; 14(3):163-9. PubMed ID: 10860714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.